Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Imaging in patients with obesity: challenges, applications and future directions

Imaging has a growing role in the evaluation of obesity-related disorders and the effects of weight loss, especially given the increasing use of glucagon-like peptide 1 agonists. New imaging biomarkers are emerging. Artificial intelligence applications for automated quantification of body composition underline future capabilities of whole-body MRI to comprehensively assess patients with obesity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Imaging biomarkers for organ-specific obesity-related conditions.

References

  1. GBD 2021 US Obesity Forecasting Collaborators. National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990-2021, and forecasts up to 2050. Lancet 404, 2278–2298 (2024).

    Article  Google Scholar 

  2. Uppot, R. N. Technical challenges of imaging & image-guided interventions in obese patients. Br. J. Radiol. 91, 20170931 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  3. Starekova, J., Hernando, D., Pickhardt, P. J. & Reeder, S. B. Quantification of liver fat content with CT and MRI: state of the art. Radiology 301, 250–262 (2021).

    Article  PubMed  Google Scholar 

  4. Wagner, R. et al. Metabolic implications of pancreatic fat accumulation. Nat. Rev. Endocrinol. 18, 43–54 (2022).

    Article  CAS  PubMed  Google Scholar 

  5. Powell-Wiley, T. M. et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 143, e984–e1010 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gandham, A. et al. Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: a systematic review and meta-analysis. Obes. Rev. 22, e13187 (2021).

    Article  CAS  PubMed  Google Scholar 

  7. Dolatshahi, M. et al. Alzheimer disease pathology and neurodegeneration in midlife obesity: a pilot study. Aging Dis. 15, 1843–1854 (2024).

    PubMed  PubMed Central  Google Scholar 

  8. Sung, H. et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J. Clin. 69, 88–112 (2019).

    PubMed  Google Scholar 

  9. Santhanam, P. et al. Artificial intelligence and body composition. Diabetes Metab. Syndr. 17, 102732 (2023).

    Article  CAS  PubMed  Google Scholar 

  10. Drucker, D. J. Discovery of GLP-1-based drugs for the treatment of obesity. N. Engl. J. Med. 392, 612–615 (2025).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mickael Tordjman.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tordjman, M., Fayad, Z.A., Benzinger, T.L.S. et al. Imaging in patients with obesity: challenges, applications and future directions. Nat Rev Endocrinol 21, 588–590 (2025). https://doi.org/10.1038/s41574-025-01166-0

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41574-025-01166-0

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing